ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
Clinical trial NCT05216224 · COMPLETED
Trial details
- NCT number
- NCT05216224
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-29
- Primary completion
- 2022-12-23
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.